发明申请
US20110263678A1 INHIBITORS OF TGF-R SIGNALING FOR TREATMENT OF CNS DISORDERS
有权
TGF-R信号传导治疗CNS疾病的抑制剂
- 专利标题： INHIBITORS OF TGF-R SIGNALING FOR TREATMENT OF CNS DISORDERS
- 专利标题（中）： TGF-R信号传导治疗CNS疾病的抑制剂
-
申请号： US13028035申请日： 2011-02-15
-
公开(公告)号： US20110263678A1公开(公告)日： 2011-10-27
- 发明人: ULRICH BOGDAHN , Ludwig Aigner , Frank-Peter Wachs , Beate Winner , Jürgen Winkler
- 申请人： ULRICH BOGDAHN , Ludwig Aigner , Frank-Peter Wachs , Beate Winner , Jürgen Winkler
- 优先权： EP04002846.6 20040209
- 主分类号： A61K31/7105
- IPC分类号： A61K31/7105 ; A61P25/18 ; A61P27/06 ; A61P25/24 ; C07H21/04 ; A61P25/28
摘要：
The present invention relates to the use of oligonucleotides for the preparation of a pharmaceutical composition for the prevention or treatment of a disease, wherein neurogenesis and/or neuroregeneration has a beneficial effect, in particular a disease like Morbus Alzheimer, Morbus Parkinson, Lewy Body Dementia,—Amyotrophic Lateral Sclerosis, Spinocerebellar Atrophies, Creutzfeldt Jakob Disease, Frontemporal Dementia, Morbus Pick, AIDS Dementia Complex, Vascular Dementia, Progressive Supranuclear Palsy, Corticobasal Degeneration, Multisystem-Atrophy, Hallervorden Spatz Disease, Huntington's disease, Stroke, Traumatic Brain and spinal cord Injury, Retinitis Pigmentosa, Macular Degeneration, Glaucoma, Cochlea Degeneration, Depression, Schizophrenia, Multiple Sclerosis, and developmental neurodegeneration.
公开/授权文献
信息查询
IPC分类:
